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ASO dislodgementObjective: Technical difﬁculties still exist for the catheter closure of atrial septal defects (ASD) in some of the
morphological features of defects, or hemodynamic features in the population. Themorphological or hemo-
dynamic features are (1) large ASD, (2) wide rim deﬁciency, (3) multiple defects, (4) severe pulmonary
hypertension, (5) ventricular dysfunction, and (6) restrictive left ventricular compliance. Our study
aimed to assess the efﬁcacy of transcatheter closure of complex ASDs under transesophageal echocardiog-
raphy (TEE) guidance in adolescents and adults, and ﬁgured out the predictors of atrial septum occluder
(ASO) dislodgement.
Methods: From June 2003 to June 2014, 125 adults and 12 adolescents were diagnosed with secundum ASD
and underwent a transcatheter closure of defects using an ASO. Among the above patients, 63 patients had
morphological or hemodynamic features that made ASD closure difﬁcult.
Results: No ASO dislodgement occurred in the non-complex ASD closure group, and an 88.9% success rate
was observed in the complex ASD closure group. Higher Qp/Qs ratio, higher incidence of multiple ASDs,
and larger ASD size in the complex ASD closure group were noted. 50.8% patients in complex ASD closure
group had ASD ≧ 30 mm. Multivariate analysis demonstrated that an occurrence of eroded and IAS or aneu-
rysm formation and arrhythmia during implantation were independent predictors for ASO dislodgement in
complex ASD closure (p = 0.005; p = 0.037).
Conclusion: Eroded and ﬂoppy IAS or aneurysm formation post ASO implantation and peri-procedure
arrhythmia could predict ASO dislodgement in complex ASD closure. Transcatheter closure of ASDs under
TEE guidance is feasible in complex cases.
© 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Atrial septal defects (ASDs) accounts for 7% of all congenital heart
diseases. The most common ASD is a secundum defect, followed by de-
fects located in the septum primum, or in the sinus venosus defects, or
in the unroofed coronary sinus [1]. If left untreated, these defects may
result in right-sided heart failure, arrhythmia, andpulmonary hyperten-
sion. Current guidelines state that the closure of an ASD with a signiﬁ-
cant shunt under either percutaneous intervention or surgery is a
class IB indication with or without symptoms. Only secundum ASD
can be treated with the percutaneous closure method, and sinus
venosus, coronary sinus, or premiumASD should be repaired surgically.
This is also a class IB indication [2,3]. Percutaneous device closure ofpartment of Internal Medicine,
Pei Road, Niao Sung District,
ng).
r.
. This is an open access article underASDs has emerged as an alternative method to traditional surgical clo-
sure due to low complication rates, short anesthetic times, and short
hospitalizations [4]. However, from a technical point of view, difﬁculties
still exist for catheter closures of ASD due to themorphological features
of the defects or hemodynamic features in the adult population. The
morphological features of complex ASD closure include (1) large
(N30 mm) ASD, (2) wide rim deﬁciency, and (3) multiple defects. The
hemodynamic features of complex ASD include (1) severe pulmonary
hypertension, (2) ventricular systolic dysfunction, and (3) restrictive
left ventricular compliance after ASD closure [5]. As the experience
and the techniques evolved, the operators are daring to take up more
challenging defects for the catheter based treatment. To the best of
our knowledge, few study was published about the result of transcath-
eter closure of complex ASDs.
Therefore, our study aimed to assess the efﬁcacy of the transcatheter
closure of complex ASDs under transesophageal echocardiography
(TEE) guidance in adolescents and adults. We also determined the
factors that inﬂuenced ASO dislodgement in the complex ASD closure
group.the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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2.1. Patient collection
From June 2003 to June 2014, 125 adults and 12 adolescents were
diagnosed with secundum ASD and underwent transcatheter closure
of their defects using an atrial septal occluder (ASO) in our hospital.
The indications for ASD closure were a signiﬁcant left to right shunt
and echocardiographic evidence of a right heart dilatation with or
without a paradoxical interventricular septal wall motion. The ASO
was implanted without balloon sizing under general anesthesia and
TEE guidance. TEE only provide two-dimensional image. Among the
above patients, 63 patients had the morphological or hemodynamic
features of a difﬁcult ASD closure and were classiﬁed into the complex
ASD closure group. 50.8% patients had ASD ≧ 30 mm, 25.4% patients
had ASD ≧ 34mm, and 9.5% patients had ASD around 38mm. Seven pa-
tients suffered from ASO dislodgement, and the other 56 patients com-
prised the successful group. Seventy-four patients did not have any
features of a difﬁcult ASD closure and were classiﬁed into the non-
complex ASD closure group. No ASO dislodgement occurred in the
non-complex ASD closure group.
2.2. Procedure and protocol
The entire procedurewas performed under general anesthesia. After
right heart and left heart diagnostic catheterization, periprocedural TEE
was conducted by an experienced pediatric cardiologist. The evaluation
of ASD included the size and position of the defect and its anatomic
relationship to the adjacent cardiac structures, including the vena
cava, atrioventricular valves, coronary sinus and all of the pulmonary
veins. The size of the ASO was selected according to the study of the
periprocedural TEE. After the wiggling test and observation, an ASO
was released via femoral venous access.
Transthoracic echocardiography, chest radiography (CXR) and elec-
trocardiography (ECG) were performed the next day after the proce-
dure. All of the patients received transthoracic echocardiographic
follow-up at 1 month, 3 months and 6 months, then changed to yearly
visit to assess the results. CXR was performed at 1 month and 6 months
to conﬁrm the position of the ASO device during the follow-up period.
2.3. Deﬁnition
In our study, we deﬁned the complex ASD closure as including at
least one of the following morphological features or hemodynamic fea-
tures as (1) large ASD (a diameter of more than or equal to 30 mm),
(2) wide rim deﬁciency, (3) multiple rim defects, (4) severe pulmonary
hypertension (a mean PA pressure greater or equal to 45 mm Hg), and
(5) ventricular dysfunction (left ventricular ejection fraction less than
50%) (Table 1).
Adolescentswere deﬁned the age between 12 to 18 years old, and an
adult was deﬁned the age over 18 years old. A ﬂoppy interatrial septum
(IAS) or aneurysm formation was deﬁned as a bulge in the atrialTable 1
Morphological features and hemodynamic features of complex ASD.
Morphological features
1 Large (≧30 mm) ASD
2 Wide rim deﬁciency
3 Multiple rim defects
Hemodynamic features
4 Severe pulmonary hypertension
(mean PAP N 45 mm Hg)
5 Ventricular dysfunction as LVEF
b50%
* Abbreviation: ASD, Atrial Septal Defects; PAP, pulmonary artery pressure; LVEF, left
ventricular ejection fraction.septum, which moved to and fro. IAS erosion was deﬁned as the abra-
sion of the atrium tissue.
2.4. Statistical analysis
The data were expressed as the mean± standard deviation. Factors
including the ASD size, mean pulmonary arterial pressure, Qp/Qs, gen-
der and ASD rims were analyzed using the chi-square test. Univariate
andmultivariate logistic regression analyseswere performed to identify
signiﬁcant predictors associated with ASO dislodgement. The level of
statistical signiﬁcance was set at p b 0.05. All of the statistical analyses
were performed using SPSS 22.0 (SPSS, Inc., Chicago, Illinois).
3. Results
3.1. Baseline characteristics of the study patients
One-hundred-thirty-seven patients underwent a transcatheter clo-
sure, and among them, 63 patients hadmorphological or hemodynamic
features of a difﬁcult ASD closure and were classiﬁed into the complex
ASD closure group, and the other 74 patients did not have any features
of a difﬁcult ASD closure and were classiﬁed into the non-complex ASD
closure group.
Younger age (42.85± 17.42 vs. 35.55± 14.56, p= 0.009), high QP/
QS ratio (2.24± 0.56 vs. 3.53± 1.36, p b 0.001), high percentage of the
QP/QS ration over 3.13 (4.1% vs. 64.5%, p b 0.001), high percentage of
multiple ASDs (0% vs. 28.6%, p b 0.001), larger ASD size (20.15 ± 6.17
vs. 28.31 ± 7.67, p b 0.001), and high percentage of the ASD diameter
over 30 mm (0% vs. 50.8%, p b 0.001) were characteristics of the com-
plex ASD closure group (Table 1). A higher incidence of ASO dislodge-
ment was observed in the complex ASD closure group (0% vs. 11.1%,
p = 0.004) (Table 1). No ASO dislodgement occurred in the non-
complex ASD closure group.
3.2. Margins and minor complications (Table 2)
The smallest rim lengthwas shorter in the non-complex ASD closure
group without statistically signiﬁcant differences (8.72 ± 4.07 vs.
8.78 ± 4.49, p = 0.936). Aortic rim deﬁciency was found among 48.4%
of the patients in the non-complex closure group and 52.7% of the
patients in the complex closure group, but did not have a statistically
signiﬁcant difference (p= 0.389). An inferior venous cava rim deﬁcien-
cy and multiple rim deﬁciency rates were higher in the complex ASD
closure group than the non-complex ASD closure group (0% vs. 11.8%,
p = 0.193) (0% vs. 4.8%, p = 0.095).
The incidence of IAS erosion,ﬂoppy IAS, or aneurysm formation after
ASO implantation was higher in the complex ASD closure group (9.5%
vs. 15.9%, p = 0.191). The incidence of arrhythmia such as an atrial ﬁ-
brillation or premature ventricular contraction or supraventricular
tachycardia during ASO implantation was higher in the complex ASD
closure group (4.1% vs. 12.7%, p = 0.061).
3.3. Comparison between the clinical characteristics of patients with
complex ASD concerning success and dislodgement (Table 3)
Among 63 patients with morphological or hemodynamic features of
a difﬁcult ASD closure, 7 patients suffered from ASO dislodgement and
56 patientswere in the successful group. Therewas no signiﬁcant differ-
ence between success and dislodgement in the clinical characteristics
such as age, gender, Qp/Qs ratio, the percentage of Qp/Qs over 3.13,
the mean PA pressure, the percentage of LVEF b 50%, the incidence of
multiple ASD, ASD size, smallest rim length, and rim deﬁciency. The
percentage of ASD diameters over 34 mm and the occurrence of
arrhythmia were higher in the dislodgement group (9.8% vs. 57.1%,
p = 0.008; 7.8% vs. 57.1%, p = 0.005; respectively).
Table 2







Age 42.85 ± 17.42 35.55 ± 14.56 0.009
Female (%) 74.3 66.7 0.213
Qp/Qs 2.24 ± 0.56 3.53 ± 1.36 b0.001
Qp/Qs N 3.13 (%) 4.1 64.5 b0.001
PA mean pressure (mm Hg) 17.85 ± 6.50 19.26 ± 8.47 0.279
PA pressure N 45 mm Hg (%) 0 3.2 0.210
ECG




LVEF b50% (%) 0 4.8 0.095
Defects
Multiple ASDs (%) 0 28.6 b0.001
ASD size (mm) 20.15 ± 6.17 28.31 ± 7.67 b0.001
ASD ≧ 30 mm (%) 0 50.8 b0.001
ASD ≧ 34 mm (%) 0 25.4 b0.001
ASD ≧ 38 mm (%) 0 9.5 0.008
Margins
Smallest rim length (mm) 8.72 ± 4.07 8.78 ± 4.49 0.936
Aortic rim deﬁciency (%) 48.4 52.7 0.389
IVC rim deﬁciency (%) 0 11.8 0.193
Multiple rims deﬁciency (%) 0 4.8 0.095
Minor complications







Dislodgement (%) 0 11.1 0.004
Follow-up time (days) 1627.10 ± 1026.58 1551.65 ± 1132.56 0.683
Data are presented as mean ± SD or number (%) of patients.
Abbreviation: PA, pulmonary artery; LVEF, left ventricular ejection fraction; ASD, atrial
septal defects; ASO, atrial septal occluder; BSA, body surface area, IAS, interatrial septum;
IVC: inferior vena cava. P values below 0.05 were considered statistically signiﬁcant.
Table 3







Age 36.30 ± 15.04 30.26 ± 11.80 0.313
Female (%) 72.5 57.1 0.407
Qp/Qs 3.60 ± 1.38 3.80 ± 1.27 0.729
Qp/Qs N 3.13 (%) 66.7 71.4 0.585
PA mean pressure (mm Hg) 19.36 ± 9.31 18.00 ± 2.94 0.704
LVEF b 50% (%) 5.9 0 0.675
Defects
Multiple ASDs (%) 11.3 20 0.406
ASD size (mm) 27.38 ± 7.72 32.21 ± 8.28 0.129
ASD size ≧ 34 mm (%) 9.8 57.1 0.008
3W.-C. Lee et al. / Clinical Trials and Regulatory Science in Cardiology 11 (2015) 1–53.4. The predictors of ASO dislodgement in the complex closure group
(Table 4)
Univariate logistic regression analysis identiﬁed that the incidence of
arrhythmia peri-ASO implantation (OR: 17.333 (95% CI: 2.837–105.885,
p = 0.002) had signiﬁcant predictive value. An ASD diameter greater
than 30 mm (OR: 6.923 (95% CI: 0.782–61.315, p = 0.082) and IAS
erosion, or ﬂoppy IAS, or aneurysm formation had a trend of statistical
difference (OR: 5.250 (95% CI: 0.965–28.553, p = 0.055), which
progressed to multivariate logistic regression analysis.
Multivariate logistic regression analysis identiﬁed that an ASD diam-
eter greater than 30 mm (OR: 16.280 (95% CI: 0.922–287.591, p =
0.057) had a trend of statistical difference. IAS erosion, or ﬂoppy IAS,
or aneurysm formation post ASO implantation (OR: 12.498 (95% CI:
1.161–134.554, p = 0.037) and the occurrence of arrhythmia peri-
ASO implantation (OR: 23.550 (95% CI: 2.563–216.377, p = 0.005)
were the predictors of an ASO dislodgement in the complex ASD closure
group.Margins
Smallest rim length (mm) 8.86 ± 4.76 8.29 ± 2.59 0.773
Aortic rim deﬁciency (%) 53.5 57.1 0.593
IVC rim deﬁciency (%) 7.7 33.3 0.350
Multiple rims deﬁciency (%) 5.9 0 0.675
Minor complications






Follow-up time (days) 1534.71 ± 1113.61 1460.14 ± 1129.35 0.869
* Data are presented as mean ± SD or number (%) of patients.
* Abbreviation: PA, pulmonary artery; LVEF, left ventricular ejection fraction; ASD, atrial
septal defects; ASO, atrial septal occluder; BSA, body surface area, IAS, interatrial septum;
IVC: inferior vena cava. P values below 0.05 were considered statistically signiﬁcant.4. Discussion
ASD accounts for 7% of all congenital heart diseases andwas found to
be the second most common CHD [1]. The clinical features of ASD are
widely varied from the pediatric population through adulthood. The
majority of these children are asymptomatic and diagnosed by school
physical examinations and a heart murmur is detected by the primary
care physician, and cardiac echocardiographic screening in during the
newborn period [6]. On the contrary, adult patientswith ASD are usually
symptomatic. Their heart diseasemay be discovered as a result of palpi-
tation, arrhythmia, or the progression of congestive heart failure. Ourrecent series of adult patients with ASD, they were diagnosed within
3 years prior to the procedure, meaning that the majority of adult pa-
tients could not be diagnosed during the pediatric period under the cur-
rent medical screening system [5]. The extrapolation of studies on
younger patients was not appropriate in the geriatric patients. First,
elder patients with ASD acquire comorbid conditions, including ar-
rhythmia, hypertension, respiratory distress, and kidney disease,
which play a signiﬁcant role in their heart conditions [6]. ASD closure
for adolescents and Adults is more difﬁcult than children. Therefore,
our study was focus on complex ASD closure in adolescents and adults.
4.1. Morphological features and hemodynamic features of difﬁcult
transcatheter ASD closure
Transcatheter closure of ASD is associated with low complication
rates, short anesthetic times, and short hospitalizations [4]. However,
procedural difﬁculties still exist due to the morphological features of
septal defects or from a hemodynamic stand point. In a review study,
Teiji Akagi stated that the morphological features of complex ASD
closure are (1) large (N30 mm) ASD, (2) wide rim deﬁciency, and
(3) multiple defects. Similarly, hemodynamic features of complex ASD
are (1) severe pulmonary hypertension, (2) ventricular dysfunction,
and (3) restrictive left ventricular compliance after ASD closure [5].
We set severe pulmonary hypertension to represent ameanPApressure
over 45 mmHg and ventricular dysfunction as LVEF b50%. We did not
include the criteria, such as restrictive left ventricular compliance after
ASD closure, because we did not perform a tissue duplex immediately
after ASO implantation.
In our study, over half patients had ASD ≧ 30mm, 25.4% patients had
ASD ≧ 34mm, and 9.5%patients hadASD around 38mmin complexASD
closure group. The accurate selection of the device size is crucial for the
success of ASD closure with an Amplatzer septal occluder. Implanting a
device that is too large may carry risks of a mushrooming deformity of
the device, impingement of the cardiovascular structure, and serious
late complications [7], while using too small of a device may cause
instability or distal embolization of the device and residual shunting
[8]. ASD is never a round structure and often it's oval in shape. Measure-
ment in long and short axis views is thus helpful in deciding the device
Table 4
Univariate analysis and multivariate cox regression analysis about ASO dislodgement of complex cases.
Univariate analysis Multivariate analysis
Variables Odd ratio 95% CI P-value Odd ratio 95% CI P-value
General demographics
Female 0.632 0.128–3.124 0.573
PA mean pressure (mm Hg) 0.976 0.872–1.093 0.676
Defects
Qp/Qs 1.184 0.630–2.224 0.599
Multiple ASD 1.000 0.176–5.693 1.000
ASD size (mm) 1.097 0.963–1.250 0.163
ASD size ≧ 30 mm 6.923 0.782–61.315 0.082 16.280 0.922–287.591 0.057
Margins
Minimal rim length (mm) 0.968 0.787–1.190 0.758
Aortic rim deﬁciency 1.227 0.248–6.079 0.802
IVC rim deﬁciency 6.500 0.280–151.123 0.244
Minor complications
Eroded and ﬂoppy IAS or aneurysm formation 5.250 0.965–28.553 0.055 12.498 1.161–134.554 0.037
Peri-procedure arrhythmia 17.333 2.837–105.885 0.002 23.550 2.563–216.377 0.005
*Abbreviation: PA, pulmonary artery; ASD, atrial septal defects; ASO, atrial septal occluder; BSA, body surface area, IAS, interatrial septum; IVC: inferior vena cava. P values below0.05were
considered statistically signiﬁcant.
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phology of the septum is crucial. Therefore, real-time three-dimensional
TEE or intracardiac echocardiography (ICE) may providemore informa-
tion.We did not use three dimensional TEE or ICE, but believe that aswe
move along this would be a very useful tool in the future in understand-
ing complex septal morphology and thus aid in catheter closures.
Currently, real-time three-dimensional TEE was limited by stitch ar-
tifacts, and required postacquisition cropping, and need more technical
experience [9]. ICE is expensive and the success rate is approximately
82% in complex ASD closure cases [10]. In our study, no dislodgement
in the non-complex ASD closure group and an 88.9% (56/63) successful
rate was found in the complex-ASD closure group and was because of
extremely complex anatomy. For seven patients with ASD diameter
around 38 mm (37.5–39.0 mm), we also successfully implanted
38mmAmplatzer ASOunder TEE guidance for ﬁve patients. One patient
experienced ASO dislodgement to right ventricular due to eroded IAS
with arrhythmia. Another patient experienced ASO dislodgement to
left atrium at recovery room due to eroded IAS post implantation. Fur-
thermore, the results of our study in the complex ASD closure group
were not inferior to those of other studies.
4.2. Predictors of ASO dislodgement
Although the complication rate following percutaneous transcathe-
ter ASD closure is low [11], the most frequent serious complications
are device dislodgement and cardiac perforation, erosion, or rupture.
The rate of ASO dislodgement was approximately 2–5.5% in previous
studies [12]. The common reasons for the ASO dislodgement are the
use of an undersized ASD device, greater defect size, the left atrium
being too small to accommodate the device, an inadequate or ﬂoppy
rim, device mobility post-implantation, and operator-related technical
issues [13]. The current guidelines do not mention any parameters
that can predict ASO dislodgement during the performance of trans-
catheter closure for ASD [3]. Previously reported predictors include
the ASD size, pulmonary arterial pressure, a high QP/QS ratio, a septal
rim length b 5 mm, a superior posterior rim or aortic rim deﬁciency
and a ﬂoppy or eroded IAS or aneurysm formation during ASO implan-
tation [14,15].
In our study, we excluded some patients with thin and inadequate
rims. Univariate analysis regarding the ASO dislodgement of complex
cases showed peri-procedure arrhythmia had signiﬁcant differences.
An ASO size ≧ 30mmand eroded and ﬂoppy IAS or aneurysm formation
post implantation had nearly signiﬁcant differences. Multivariate cox
regression analysis of the ASO dislodgement of the complex cases
showed that an eroded and ﬂoppy IAS or aneurysm formation postASO implantation and peri-procedure arrhythmia had signiﬁcant
differences.
Percutaneous transcatheter ASD closure is not a complication-free
technique. Procedural difﬁculties still exist due to morphological fea-
tures and hemodynamic features. The success of complex ASD closure
mainly lies on the proper image techniques. TEE could provide good
image for complex cases, but still had some limitation to evaluate
whole rim morphology. New imaging modalities such as real-time
three-dimensional transesophageal echocardiography and ICE, could
provide for the high quality imaging for anatomical evaluations, includ-
ing the maximum defect size, surrounding rim morphology, and the
relationship between the device and septal rim [5]. However, ICE and
real-time three-dimensional TEE are expensive and require more tech-
nical experience. In many countries, these expensive image tools
couldn't be used for all patients. In the future, new imaging modalities
should be used to evaluate the defects of selectively complex ASD
closure as with an ASD diameter over 30 mm or the occurrence of
peri-procedure arrhythmia or eroded and ﬂoppy IAS or aneurysm for-
mation post ASO implantation.4.3. Limitations
Our study was a retrospective report without prospective randomi-
zation. Selection bias may have existed during the procedure. Only one
brand of ASOwas used [Amplatzer ASO (AGAMedical Corporation, MN,
USA)] in our hospital. The largest ASO is 38 mm. The numbers of ASO
dislodgement were also limited.5. Conclusions
Eroded and ﬂoppy IAS or aneurysm formation post ASO implanta-
tion and peri-procedure arrhythmia could predict ASO dislodgement
in complex ASD closure. Transcatheter closure of ASDs under TEE
guidance is feasible in complex cases.Contributorship
Wei-Chieh Lee, Chih-Yuan Fang, Chien-Fu Huang, Ying-Jui Lin,
Chiung-Jen Wu and Hsiu-Yu Fang were involved in the design of the
study. Wei-Chieh Lee and Hsiu-Yu Fang analyzed the data. Chih-Yuan
Fang, Chien-Fu Huang, Ying-Jui Lin and Chiung-Jen Wu interpreted the
data. Wei-Chieh Lee drafted the manuscript and all authors were re-
sponsible for critically reviewing it and approving the ﬁnal submission.







[1]. Hoffman JI, Kaplan S. The incidence of congenital heart disease. J Am Coll Cardiol
2002;39:1890–900.
[2]. Webb G, Michael AG. Atrial septal defects in the adult recent progress and over-
view. Circulation 2006;114:1645–53.
[3]. Warnes CA, Williams RG, Bashore TM, Child JS, Connolly HM, Dearani JA, del Nido P,
Fasules JW, Graham Jr TP, Hijazi ZM, Hunt SA, King ME, Landzberg MJ, Miner PD,
RadfordMJ. ACC/AHA 2008 Guidelines for theManagement of Adults With Congen-
ital Heart Disease. A Report of the American College of Cardiology/American Heart
Association Task Force on Practice Guidelines (Writing Committee to Develop
Guidelines on the Management of Adults With Congenital Heart Disease). Circula-
tion 2008;118:e714–833.
[4]. Du ZD, Koenig P, Cao QL, Waight D, Heitschmidt M, Hijazi ZM. Comparison of trans-
catheter closure of secundum atrial septal defect using the Amplatzer septal
occluder associated with deﬁcient versus sufﬁcient rims. Am J Cardiol 2002;90:
865–9.[5]. Akagi T. Current concept of transcatheter closure of atrial septal defect in adults.
J Cardiol 2015;65:17–25.
[6]. Nakagawa K, Akagi T, Taniguchi M, Kijima Y, Kusano K, Itoh H, Sano S. Transcatheter
closure of atrial septal defect in a geriatric population. Catheter Cardiovasc Interv
2012;80:84–90.
[7]. Divekar A, Gaamangwe T, Shaikh N, Raabe M, Ducas J. Cardiac perforation after
device closure of atrial septal defects with the Amplatzer septal occluder. J Am
Coll Cardiol 2005;45:1213–8.
[8]. Du ZD, Cao Q, Rhodes J, HeitschmidtM, Hijazi ZM. Choice of size and results of trans-
catheter closure of atrial septal defect using the Amplatzer septal occluder. J Interv
Cardiol 2002;15:287–92.
[9]. Assaidi A, Sumian M, Mauri L, Mancini J, Ovaert C, Salaun E, Habib G, Fraisse A.
Transcatheter closure of complex atrial septal defects is efﬁcient under intracardiac
echocardiographic guidance. Arch Cardiovasc Dis 2014;107:646–53.
[10]. Huang T-C, Lee C-L, Lin C-C, Hsieh K-S. Transcatheter closure of atrial septal defects
with the amplatzer septal occluder- clinical results. Acta Cardiol Sin 2004;20:223–8.
[11]. Delaney JW, Li JS, Rhodes JF. Major complications associated with transcatheter
atrial septal occluder implantation: a review of the medical literature and the
manufacturer and user facility device experience (MAUDE) database. Congenit
Heart Dis 2007;2:256–64.
[12]. Chessa M, Carminati M, Butera G, Bini RM, Drago M, Rosti L, Giamberti A, Pomè G,
Bossone E, Frigiola A. Early and late complications associated with transcatheter
occlusion of secundum atrial septal defect. J Am Coll Cardiol 2002;39:1061–5.
[13]. Majunke N, Bialkowski J, Wilson N, Szkutnik M, Kusa J, Baranowski A, Heinisch C,
Ostermayer S, Wunderlich N, Sievert H. Closure of atrial septal defect with the
Amplatzer septal occluder in adults. Am J Cardiol 2009;103:550–4.
[14] LeeWC, Fang CY, Huang CF, Lin YJ, Wu CJ, Fang HY. Predictors of Atrial Septal Defect
Occluder Dislodgement. Int Heart J 2015;56:428–31.
[15]. Kammache I, Mancini J, Ovaert C, Habib G, Fraisse A. Feasibility of transcatheter
closure in unselected patients with secundum atrial septal defect, using amplatzer
devices and a modiﬁed sizing balloon technique. Catheter Cardiovasc Interv 2011;
78:665–74.
